Get started
Author

Heba E. El-Nakib

Observed name: Heba E. Elnakib
Observed institution: German University in Cairo
ORCID: 0009-0000-4930-0723
Observed ORCID: 0009-0000-4930-0723
OpenAlex ID: A5082973277
Design, synthesis, and metabolite identification of Tamoxifen esterase-activatable prodrugs
2022 · Rahma M. Elbagoury, Miriam A. Shenouda, et al. · Bioorganic Chemistry · 11
PDF
Manipulating Estrogenic/Anti-Estrogenic Activity of Triphenylethylenes towards Development of Novel Anti-Neoplastic SERMs
2021 · Heba E. Elnakib, Marian M. Ramsis, et al. · International Journal of Molecular Sciences · 9
PDF
Structure–Activity Relationships of Triphenylethylene Derivatives and Their Evaluation as Anticancer and Antiviral Agents
2023 · Nermin S. Ahmed, Heba E. El-Nakib, et al. · ACS Omega · 5
PDF
Analytical Methodologies for Anti-Infective Orphan Drugs: A Comprehensive Review of FDA Approvals (2013-2023) Part 1
2025 · Shimaa E. Abdel Aziz, Heba E. El-Nakib, et al. · Critical Reviews in Analytical Chemistry · 1
Analytical Methodologies for Anti-Infective Orphan Drugs: A Comprehensive Review of FDA Approvals (2013–2023) Part 2
2025 · Heba E. El-Nakib, Shimaa E. Abdel Aziz, et al. · Critical Reviews in Analytical Chemistry
Works count: 5
Citation count: 26
H-index: 3
I10-index: 1
Year
Topic
Type